Background: Although the need for intraoperative shunting during carotid endarterectomy (CEA) is intensely debated, relatively few studies have compared the neurologic outcomes of patients undergoing CEA with or without shunts. The objective of our analysis was to determine the impact of intraoperative shunting during CEA on the incidence of postoperative stroke. Methods: The 2012 CEA-targeted American College of Surgeons National Surgical Quality Improvement Program database was used for this analysis. The preoperative and operative characteristics of patients undergoing CEA with or without intraoperative shunting were compared. From this overall sample, propensity score techniques were then used to match patients with or without intraoperative shunting for a number of variables, including age, degree of ipsilateral and contralateral carotid stenosis, presence of several anatomic or physiologic risk factors, anesthesia modality, and use of patch angioplasty vs primary arteriotomy closure. The 30-day postoperative mortality and combined stroke/transient ischemic attack (TIA) rates of this matched cohort were then compared. A similar analysis was also performed on a subgroup of patients with severe stenosis or occlusion of the contralateral carotid artery. Results: A total of 3153 patients were included for initial analysis (2023 "no-shunt" patients vs 1130 "shunt" patients). From this overall sample, propensity score matching yielded a cohort of 1072 patients with or without intraoperative shunt placement who were well matched for all known patient-and procedure-related factors. There was no significant difference in the incidence of postoperative stroke/TIA between the two groups of this matched cohort (3.4% in the no-shunt group vs 3.7% in the shunt group; P [ .64). Analysis of a similarly well matched subgroup of patients with severe stenosis or occlusion of the contralateral carotid artery demonstrated a statistically nonsignificant increase in the incidence of postoperative stroke/TIA with the use of intraoperative shunting (4.9% in the no-shunt group vs 9.8% in the shunt group; P [ .08).
Whether intraoperative shunting should be used routinely, selectively, or not at all during carotid endarterectomy (CEA) is controversial. Some surgeons argue that routine shunt use minimizes the risk of ipsilateral cerebral hypoperfusion during carotid arterial clamping and enables endarterectomy to be performed in an unhurried manner. 1, 2 Other surgeons argue that shunt use is unnecessary both because cerebral hypoperfusion is a relatively uncommon cause of perioperative stroke in patients who undergo CEA and because the actual placement of a shunt can precipitate carotid arterial injury or the generation of distal emboli. [3] [4] [5] Finally, still other surgeons favor placement of shunts only in those patients who show evidence of neurophysiologic derangement or inadequate carotid arterial backflow during test-clamping of the ipsilateral internal carotid artery (ICA) because such a strategy allows the theoretical benefits of shunting for high-risk patients but avoids the potential complications of shunt placement in low-risk patients. 2, 6 In addition to these theoretical arguments, proponents of each of the three shunting (or nonshunting) strategies can also cite multiple single-center case series from the literature demonstrating that their preferred approach can be pursued with an acceptably low incidence of perioperative stroke, even in the setting of high-risk conditions such as contralateral carotid occlusion. 2, 4, [7] [8] [9] [10] [11] [12] [13] [14] To date, relatively few studies have been published in which the early neurologic outcomes of patients undergoing CEA with or without shunting have been directly compared, and the collective results of these studies do not clearly favor or disfavor any one of the three potential approaches to shunt use. 2, 6, 9, [15] [16] [17] [18] The recent development of "procedure-targeted" data repositories by the American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP) offers a unique opportunity to contribute further to our knowledge about specific questions such as the need for shunting during CEA. 19 Unlike previous ACS NSQIP data files, the procedure-specific databases contain information about risk factors and outcomes that may be of unique interest to participating hospitals where those procedures are frequently performed. For example, the CEA-targeted database contains information about variables such as intraoperative shunt and a host of other variables of specific interest in assessing the early outcomes after CEA. On the basis of the theoretical rationale for shunt use, we hypothesized that shunted patients would have a lower incidence of perioperative stroke than otherwise similar patients who did not undergo intraoperative shunting.
METHODS
The 2012 ACS NSQIP Procedure Targeted Carotid Open Participant Use Data File (PUF) and the larger 2012 ACS NSQIP Participant User File were merged to perform this analysis. The larger data set contains information about 543,885 general and subspecialty procedures (including CEA) performed at 374 participating academic and community hospitals in the United States. 20 Because larger hospitals may not be able to capture all of the surgical cases that meet the ACS NSQIP inclusion criteria, a systematic sampling system is used to prevent bias in choosing cases for assessment. The database is therefore not population based. Information captured in the larger data set includes patient demographics, comorbid illnesses, perioperative variables, and 30-day postoperative mortality and morbidity data. Each variable included within the database is strictly defined to ensure uniformity, and the information about each variable is prospectively collected by on-site ACS-trained clinical reviewers. Periodic auditing of these reviewers has demonstrated the data contained within the database to be highly reliable, with interobserver disagreement occurring at a rate of only 2%. 20 The 2012 CEAtargeted database contains more detailed disease-and procedure-specific information about select patients from the larger data set who underwent CEA. In 2012, 78 centers participated in the CEA-targeted ACS NSQIP program. The additional information that is available in the CEA-targeted database includes the degree of ipsilateral and contralateral carotid arterial occlusion, the presence and type of preoperative symptoms that were present and attributable to carotid stenosis, and the intraoperative use of carotid shunts. 20 Neither the larger ACS NSQIP PUF nor the CEA-targeted PUF contains hospital identifiers. It is therefore not possible to determine center-specific information, such as annual CEA volume or center-specific postoperative outcomes.
Patients from this data source were included for analysis if they were documented to have undergone any of the following procedures: CEA, CEA with shunt, CEA with patch angioplasty, or CEA with patch angioplasty and shunt. Patients who underwent eversion CEA (in whom the use or nonuse of a shunt was not documented by the ACS NSQIP) or in whom the procedure type was not documented were excluded from analysis. Patients were also excluded from analysis if they had missing data for any of the variables included for analysis.
The primary predictor variable for our analysis was the presence or absence of an intraoperative shunt during CEA. Other predictor variables used in our analysis included the following: the patient's age and gender; the presence of one or more physiologic high-risk factors, including class III or IV New York Heart Association congestive heart failure, left ventricular ejection fraction <30%, unstable angina within 30 days before surgery, or myocardial infarction within 30 days before surgery; bleeding disorder, including the ongoing use of anticoagulation therapy immediately before surgery; ipsilateral ICA stenosis $80% as determined by preoperative Doppler ultrasound, computed tomography angiography, or magnetic resonance angiography; presence of contralateral ICA occlusion as determined by preoperative imaging; presence of preoperative neurologic symptoms, classified for the purposes of this analysis as none/asymptomatic, ipsilateral transient ischemic attack (TIA) or amaurosis fugax, or ipsilateral cerebrovascular accident; preprocedural antiplatelet therapy; preprocedural statin therapy; preprocedural b-blocker therapy; presence of one or more anatomic high-risk factors, including previous ipsilateral CEA/carotid stenting, previous ipsilateral radical neck dissection, contralateral common carotid or ICA occlusion, prior radiation to neck, contralateral laryngeal nerve injury or palsy, and anatomic lesion at the second cervical vertebral level or higher; use of locoregional anesthesia (vs general anesthesia); operative time; and use of patch angioplasty for closure of the carotid arteriotomy. The primary outcomes for our analysis were 30-day postoperative mortality rate and the combined 30-day incidence of postoperative stroke/TIA. These outcomes are determined by an ACS-trained clinical nurse reviewer, who documents the presence of an adverse postoperative event if there is any mention of that event in the reviewer's prospective review of a patient's medical record or discharge summary. 20 The secondary outcome for our analysis was the day of diagnosis of postoperative stroke/TIA (in those patients who sustained such an event), which was classified as either the day of operation (and therefore potentially the result of intraoperative cerebral hypoperfusion related to carotid arterial clamping) or later.
With all patients from the 2012 Procedure Targeted Carotid Open ACS NSQIP sample who had known data for each of the predictor variables, including the degree of contralateral ICA stenosis, univariate comparison of patient-and procedure-related characteristics and 30-day postoperative outcomes of the "no-shunt" vs "shunt" patients was performed by Pearson c 2 tests for categorical variables and Wilcoxon rank sum tests for continuous variables. In an attempt to adjust for the fact that some surgeons place shunts only in those patients who they perceive to be at high risk for intraoperative cerebral hypoperfusion, we next conducted a separate analysis using a subset of the entire ACS NSQIP patient sample that was matched on propensity for undergoing the procedure with intraoperative shunting. For this analysis, a logistic regression model was created to estimate the likelihood of undergoing CEA with an intraoperative shunt. All of the patient-and procedure-related variables were included in this model as potential predictors of intraoperative shunt use. The logit coefficients for the predictors of intraoperative shunting that were derived from this regression model were then used to calculate a propensity score for intraoperative shunt use for each patient from the overall study sample. This propensity score ranged from 0 to 1 and essentially represents the likelihood that a patient would receive an intraoperative shunt on the basis of the unique array of patient-and disease-related characteristics. These propensity scores were then used to create an evenly matched cohort of no-shunt and shunt patients by a caliper matching algorithm (with caliper distance of 0.01), with controls being used only once in the matching. The desired result of this process was to pair as many shunt patients as possible with a corresponding no-shunt patient who was otherwise similar with respect to the comorbid and carotid disease profiles. Comparisons of these characteristics and the postoperative outcomes of this matched cohort of patients were then performed by McNemar c 2 tests for binary categorical variables, conditional logistic regression for multilevel categorical variables, and Wilcoxon signed rank sum test for continuous variables.
The analysis included all patients with known degree of contralateral carotid artery stenosis. A second analysis was then performed on the subset of patients from that cohort who exhibited severe stenosis (80%-99%) or occlusion of the contralateral ICA on preoperative imaging and in whom intraoperative shunting would therefore be expected to offer the greatest potential benefit in reducing the incidence of stroke due to intraoperative cerebral hypoperfusion. [21] [22] [23] All statistical analyses were performed with Stata version 11.0 (StataCorp, College Station, Tex).
RESULTS
The 2012 CEA-targeted ACS NSQIP database contains records from 4013 CEA procedures. Of this total, 860 were excluded from our analysis because of either their undergoing eversion CEA (and in whom the use or nonuse of a shunt could not be confirmed; 215 patients) or missing data for one or more of the variables considered in our analysis (598 patients). The most common reason for exclusion was missing data for the degree of contralateral carotid artery stenosis (missing in 490 patients). A total of 3151 meeting the inclusion and exclusion criteria of our study were therefore included for analysis (2023 noshunt patients vs 1130 shunt patients). The patient-and procedure-related characteristics of these patients are shown in Table I . Patients in the shunt group were more likely to be female, to have occlusion of the contralateral ICA, and to have the carotid arteriotomy closed with a patch. Patients in the no-shunt group were more likely to undergo CEA with locoregional anesthesia. There was a statistically but not clinically significant difference in the operative duration of procedures performed with and without intraoperative shunting. The overall combined 30-day incidence of postoperative stroke/TIA was 3.7% and did not differ on univariate comparison of the two groups (3.6% for no-shunt patients vs 4.0% for shunt patients; P ¼ .55). The overall 30-day mortality rate was 0.9% and was higher for shunted patients (0.6% for noshunt patients vs 1.3% for shunt patients; P ¼ .05). Among the 76 patients from our overall study sample who experienced a postoperative stroke or TIA, the day of diagnosis of the event was known for 64 (28 of 36 no-shunt patients [78%] vs 36 of 40 shunt patients [90%]; P ¼ .32]. Univariate comparison of these patients showed that a significantly greater proportion from the shunt group had the neurologic event diagnosed on the day of operation compared with patients from the no-shunt group (38.9% of shunt patients vs 17.9% of no-shunt patients; P ¼ .02).
A total of 2144 patients from the overall study sample were matched on the basis of their propensity to undergo intraoperative shunting during CEA. From the overall study sample, 58 shunt patients could not be suitably matched to any of the available no-shunt patients and were therefore not included in the propensity-matched analysis. There were no significant differences in the 1072 matched pairs of no-shunt and shunt patients in any of the known patient-or procedure-related characteristics (Table II) . Fig 1 demonstrates no significant difference in the 30-day postoperative mortality or combined stroke/ TIA rates for no-shunt and shunt patients from this matched cohort. In addition, there was no significant difference between the two groups from the matched cohort in the percentage of postoperative neurologic deficits that were diagnosed on the day of operation (20% of noshunt patients who experienced postoperative stroke/TIA vs 42% of shunt patients; P ¼ .32).
Of the 3151 patients in our overall study sample, 373 had severe stenosis (n ¼ 224) or occlusion (n ¼ 149) of the contralateral carotid artery on preoperative imaging and might therefore be considered to be at high risk for clamp-induced cerebral hypoperfusion during CEA. Of these patients, 171 underwent CEA with and 202 without an intraoperative shunt. Previously described propensity score matching techniques were applied to this subgroup and resulted in a cohort of 123 no-shunt and 123 shunt patients who were well matched for known patient-and procedure-related variables (Table III) . Fig 2 shows that the shunt patients from this cohort had higher rates of postoperative mortality (4.1% for shunt patients vs 0.8% for no-shunt patients; P ¼ .10) and combined stroke/ TIA (9.8% for shunt patients vs 4.9% for no-shunt patients; P ¼ .08), although these differences did not reach statistical significance.
DISCUSSION
In this study, we have compared the postoperative neurologic outcomes of CEA patients with and without intraoperative shunting who were well matched for a number of relevant patient-and procedure-related variables and found that shunt use had no impact on 30-day postoperative mortality or combined stroke/TIA rates. When similar analyses were confined only to those patients with severe stenosis or occlusion of the contralateral carotid artery, shunt use during CEA was associated with twofold greater incidence of postoperative stroke/TIA. On the basis of these findings, we reject the hypothesis that intraoperative carotid shunt placement will reduce the incidence of perioperative stroke during CEA, even among those patients who are at highest theoretical risk for clamp-induced cerebral hypoperfusion.
Few published studies have directly compared the outcomes of CEA procedures that are performed with or without intraoperative shunt use. Gumerlock and Neuwelt prospectively compared the 30-day outcomes of 63 patients undergoing CEA with a shunt with those of 75 patients undergoing the procedure without a shunt and found a significantly greater incidence of postoperative stroke in the nonshunted group (8% vs 0.5%). 17 The authors concluded that shunt use reduced the risk of postoperative stroke, although their trial lacked true randomization and there was some imbalance in the preoperative characteristics of the two groups. Conversely, Palombo et al compared the outcomes in 96 CEA patients randomized to the use or nonuse of an intraoperative shunt and observed no perioperative strokes in either group. 16 In addition, the authors reported no difference between the two groups in the degree of subtle cerebral damage postoperatively (as measured by intraoperative neuroinflammatory marker assays and postoperative neuropsychological testing), but patients with severe stenosis or occlusion of the contralateral carotid artery were excluded from the Palombo trial. Finally, Sandmann et al demonstrated no significant difference in the incidence of postoperative stroke between 215 patients randomized to undergo CEA with a shunt and 243 patients randomized to undergo the procedure without a shunt (4.2% vs 3.3%; P ¼ not significant). 18 However, 45 additional patients from that trial who initially underwent randomization to one or another group were excluded from primary analysis either because shunt placement was not technically possible or because the results of intraoperative neurophysiologic testing resulted in shunt use even though a patient had been randomized to the nonshunt arm of the study. An additional limitation of that trial was the significant proportion of patients (43%) who required revision of the arteriotomy closure because of suboptimal hemodynamics observed on post-CEA intraoperative Doppler spectral analysis. These three prospective studies were subjected to meta-analysis and found to collectively provide insufficient evidence to support or to refute the use of routine shunting during CEA. 6 Several other studies have reported the outcomes of CEA performed with and without shunting but within the context of comparing routine and selective shunting strategies. For example, AbuRhama et al randomized 200 CEA patients to routine shunting vs shunt use dictated by carotid systolic stump pressure. 9 The 30-day postoperative stroke rate for the 127 patients who received a shunt (as part of either the routine or selective strategy) was 0%, whereas the rate for 73 patients whose carotid stump pressures did not qualify them for shunts was 2.7%. The authors concluded that either a routine or selective approach to shunting was acceptable, but they were unable to comment on the potential merits of a routine nonshunting approach. Of note, both of the postoperative strokes in the AbuRhama study, although occurring in patients who did not undergo shunting, were determined on reoperation to be the result of technical complications resulting in ipsilateral carotid thrombosis and not due to clamp-induced cerebral hypoperfusion. A second study by Goodney et al examined the shunting practice patterns of surgeons from the Vascular Study Group of New England in CEA patients with contralateral carotid occlusion. 15 The authors analyzed the 30-day combined postoperative stroke/death rates of three patient groups: those who received a shunt by a surgeon who routinely shunts, those who received a shunt by a surgeon who selectively shunts, and those who did not receive a shunt. The authors classified individual surgeons as selective shunters if #95% of that surgeon's CEA patients received shunts. The combined stroke/death rates were 1.5% for patients who were shunted by a routine shunter, 3.4% for patients who were not shunted, and 7.6% for patients who were shunted by a selective shunter (P ¼ .05 for trend). Because the expected stroke/death rates of these three patient groups were similar, the authors of the study concluded that intraoperative shunt use in patients with contralateral carotid occlusion during CEA can reduce their risk of adverse postoperative outcomes, but only when it is placed by a surgeon who routinely places shunts. Our analysis, among the largest to date to assess the impact of shunting on neurologic outcomes after CEA, demonstrates no discernible benefit to shunt use. On the contrary, the shunted patients in our matched cohort of high-risk patients (ie, those with high-grade stenosis or occlusion of the contralateral carotid artery) sustained a twofold greater incidence of postoperative stroke/TIA compared with the nonshunted patients, although this difference did not reach statistical difference. If the shunting surgeons who contributed to our data set were predominantly selective instead of routine shunters and are therefore comparatively less experienced with shunt placement techniques, this finding might reasonably be interpreted as an argument against the practice of selective shunting (instead of routine shunting or nonshunting). However, our lack of knowledge about the individual practice patterns of contributing surgeons precludes us from making definitive conclusions about the comparative efficacies of the three different approaches to carotid shunting. Nevertheless, only a minority of the nonshunted patients in either our overall study sample or in our subgroup of high-risk patients who suffered perioperative stroke did so on the day of their operation. This finding supports the results of previous studies that have shown clamp-induced cerebral hypoperfusion to be a relatively uncommon cause of perioperative stroke in CEA patients, even in those patients with contralateral carotid occlusion. 16, 24, 25 Our study has several limitations. The first is our inability to account for the practice patterns of individual surgeons who performed the procedures that were included for analysis. Thus, we are unable to ascertain whether the outcomes achieved by surgeons who routinely shunt during CEA might differ from those of surgeons who shunt only selectively or if factors such as the patency status of a patient's vertebral arteries might have influenced the decisions of individual surgeons to use a shunt during CEA. Second, we were unable to determine if neurophysiologic monitoring was used during procedures that were performed under general anesthesia and if such monitoring, when used, resulted in the placement of a shunt because of either neurologic derangement or inadequate stump pressure. Similarly, we do not know whether other neuroprotective adjuncts, such as vasopressor-induced cerebral hyperperfusion, might have been employed in noshunt patients during carotid arterial clamping or whether the type of patch used in those patients who received patch angioplasty after endarterectomy might have confounded our comparison of the outcomes of shunt vs no-shunt patients. Although our propensity score matching algorithm included several variables of particular import in considering the potential impact of shunt placement on CEA outcomes, it is possible that shunt patients in the matched cohorts of our study were at higher risk for perioperative stroke in ways that we could not account for. Third, the data source used for our analysis does not provide information about the relative timing of cerebral ischemic events and CEA. For this reason, we cannot adjust for the possibility that intraoperative shunts were used preferentially in patients with recent ischemic events who may be at higher risk for adverse postoperative neurologic outcomes. Similarly, the absence of hospital identifiers in the ACS NSQIP PUFs prevents us from determining centerspecific postoperative outcomes or the annual volume of CEA procedures for each of the centers that contributed information to the 2012 CEA-targeted data set. An additional limitation of our analysis is that 58 shunt patients from our original study sample were not included in the propensitymatched analysis. However, given the relatively high rate of postoperative stroke demonstrated for these 58 patients, we find it unlikely that modification of our propensity matching algorithm to capture these patients would significantly alter the conclusions of our study. Finally, although the sample size of our study compares favorably with that of other studies that have examined the impact of intraoperative shunting on post-CEA outcomes, our conclusion of "no difference" between the shunt and no-shunt groups with respect to postoperative stroke rate is subject to a high probability of type II error. This is particularly true for our subgroup analysis of high-risk patients with severe stenosis or occlusion of the contralateral carotid artery.
CONCLUSIONS
Recognizing these important limitations, the results of our analysis suggest that intraoperative shunting during CEA does not result in a reduction in the risk of perioperative neurologic events, even in those patients who may be at particularly high risk of clamp-induced cerebral hypoperfusion because of severe contralateral carotid disease. The findings of our study therefore contribute to a growing body of evidence suggesting that intraoperative shunting, despite its theoretical benefit, does not provide a discernible clinical benefit in patients who undergo CEA. The potential impact of intraoperative shunting on post-CEA outcomes merits revisiting in coming years as the size and therefore statistical power of the CEA-targeted ACS NSQIP database accrues more patients. 
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